Skip to main content
NVDA-0.31%AAPL+1.31%GOOGL-2.28%MSFT+0.02%AMZN+0.18%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.24%TSLA-0.41%SKHY+7.05%MU-1.21%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.55%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.59%0005.HK-0.78%HSBA.L-1.33%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.13%CHFJPY-1.59%AUDJPY-1.44%USDJPY-1.43%EURJPY-1.33%CADJPY-1.26%GBPJPY-1.26%NZDCAD-0.88%GBPNZD+0.87%EURNZD+0.83%NZDUSD-0.72%AUDNZD+0.71%NZDCHF-0.56%GBPTRY+0.41%USDNOK+0.36%USDZAR+0.35%GBPHKD+0.32%GBPCHF+0.32%CADCHF+0.31%GBPZAR+0.30%EURNOK+0.29%EURZAR+0.29%GBPMXN-0.28%EURCHF+0.26%CHFNOK+0.24%AUDCAD-0.20%SGDJPY+0.20%USDCHF+0.17%USDTHB+0.17%GBPUSD+0.17%USDSEK+0.17%USDILS+0.16%GBPAUD+0.16%AUDCHF+0.16%PLNJPY+0.15%USDCAD-0.15%AUDNOK+0.15%USDPLN+0.15%AUDDKK-0.14%NZDSGD+0.12%EURAUD+0.12%USDMXN+0.11%USDTRY+0.11%USDSGD+0.11%AUDSGD-0.10%NZDMXN+0.10%EURSEK+0.10%EURUSD+0.10%EURPLN+0.08%EURHKD-0.08%USDDKK+0.07%EURCZK-0.06%EURCNH-0.06%EURCAD-0.06%NOKJPY-0.06%CHFSEK+0.05%EURGBP-0.05%GBPSGD+0.04%EURSGD+0.04%USDCOP-0.04%USDCNH-0.01%USDHKD+0.01%AUDUSD-0.01%GBPCAD-0.01%CHFSGD-0.01%EURDKK0.00%HG1-3.85%COFFEE-2.30%XPTUSD-2.20%GAGUSD-1.66%XAGUSD-1.66%SUGAR+1.64%COCOA-1.58%COTTON+1.05%C1+0.52%S1+0.50%XNGUSD-0.36%GAUUSD-0.36%BTCUSD-0.35%ETHUSD+0.06%USDTUSD-0.08%XRPUSD-1.21%SOLUSD-0.33%TRXUSDT+0.45%ZECUSDT-1.48%DOGEUSD-0.97%XMRUSDT-1.25%LINKUSD-0.01%XLMUSD-0.82%BCHUSDT-2.25%LTCUSD-1.49%UNIUSD-1.79%TONUSD+24.88%HBARUSDT-1.10%SUIUSD-1.27%TAOUSDT-0.82%AAVEUSD-1.89%DOTUSDT-2.01%ICPUSDT-0.76%ONDOUSDT-1.76%WLDUSDT-1.23%ATOMUSDT-2.65%ARBUSDT-0.10%JUPUSDT-2.53%INJUSDT-1.93%STXUSDT-2.70%FETUSDT-2.45%TIAUSDT-0.34%SEIUSDT-1.80%PYTHUSDT-0.97%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.27%OPUSDT-1.99%POLUSDT-6.20%IOTAUSDT-2.03%AXSUSDT-1.71%FARTCOINUSDT-1.48%EOSUSDT+0.06%DYDXUSDT+0.19%ORDIUSDT+0.60%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.31%AAPL+1.31%GOOGL-2.28%MSFT+0.02%AMZN+0.18%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.24%TSLA-0.41%SKHY+7.05%MU-1.21%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.55%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.59%0005.HK-0.78%HSBA.L-1.33%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.13%CHFJPY-1.59%AUDJPY-1.44%USDJPY-1.43%EURJPY-1.33%CADJPY-1.26%GBPJPY-1.26%NZDCAD-0.88%GBPNZD+0.87%EURNZD+0.83%NZDUSD-0.72%AUDNZD+0.71%NZDCHF-0.56%GBPTRY+0.41%USDNOK+0.36%USDZAR+0.35%GBPHKD+0.32%GBPCHF+0.32%CADCHF+0.31%GBPZAR+0.30%EURNOK+0.29%EURZAR+0.29%GBPMXN-0.28%EURCHF+0.26%CHFNOK+0.24%AUDCAD-0.20%SGDJPY+0.20%USDCHF+0.17%USDTHB+0.17%GBPUSD+0.17%USDSEK+0.17%USDILS+0.16%GBPAUD+0.16%AUDCHF+0.16%PLNJPY+0.15%USDCAD-0.15%AUDNOK+0.15%USDPLN+0.15%AUDDKK-0.14%NZDSGD+0.12%EURAUD+0.12%USDMXN+0.11%USDTRY+0.11%USDSGD+0.11%AUDSGD-0.10%NZDMXN+0.10%EURSEK+0.10%EURUSD+0.10%EURPLN+0.08%EURHKD-0.08%USDDKK+0.07%EURCZK-0.06%EURCNH-0.06%EURCAD-0.06%NOKJPY-0.06%CHFSEK+0.05%EURGBP-0.05%GBPSGD+0.04%EURSGD+0.04%USDCOP-0.04%USDCNH-0.01%USDHKD+0.01%AUDUSD-0.01%GBPCAD-0.01%CHFSGD-0.01%EURDKK0.00%HG1-3.85%COFFEE-2.30%XPTUSD-2.20%GAGUSD-1.66%XAGUSD-1.66%SUGAR+1.64%COCOA-1.58%COTTON+1.05%C1+0.52%S1+0.50%XNGUSD-0.36%GAUUSD-0.36%BTCUSD-0.35%ETHUSD+0.06%USDTUSD-0.08%XRPUSD-1.21%SOLUSD-0.33%TRXUSDT+0.45%ZECUSDT-1.48%DOGEUSD-0.97%XMRUSDT-1.25%LINKUSD-0.01%XLMUSD-0.82%BCHUSDT-2.25%LTCUSD-1.49%UNIUSD-1.79%TONUSD+24.88%HBARUSDT-1.10%SUIUSD-1.27%TAOUSDT-0.82%AAVEUSD-1.89%DOTUSDT-2.01%ICPUSDT-0.76%ONDOUSDT-1.76%WLDUSDT-1.23%ATOMUSDT-2.65%ARBUSDT-0.10%JUPUSDT-2.53%INJUSDT-1.93%STXUSDT-2.70%FETUSDT-2.45%TIAUSDT-0.34%SEIUSDT-1.80%PYTHUSDT-0.97%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.27%OPUSDT-1.99%POLUSDT-6.20%IOTAUSDT-2.03%AXSUSDT-1.71%FARTCOINUSDT-1.48%EOSUSDT+0.06%DYDXUSDT+0.19%ORDIUSDT+0.60%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
DT

Design Therapeutics, Inc. (DSGN)

NASDAQ • Healthcare

$15.02
-$0.21 (-1.4%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$15.12
Day Range$14.87 - $15.49
Avg. Volume (3M)586.1K
Market Cap$938.1M
52 Week Range
$5.28$17.25
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$70.7M
EPS (TTM)
-$1.18
ROA (TTM)
-32.91%
Current Ratio
18.86

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+28.9%Q1 2026-$0.27
+19.4%Q2 2026-$0.29
+7.1%Q3 2026-$0.32
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Design Therapeutics, Inc.

Design Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing medicines for genetic disorders rooted in nucleotide repeat expansions. In qualitative terms, it is an early-stage biotech business. The company centers its work on GeneTAC, a product candidate platform aimed at monogenic conditions caused by these repeat-driven defects.

Name
Design Therapeutics, Inc.
CEO
Pratik Shah
Website
www.designtx.com
Industry
Healthcare
Year Founded
2017
Employees
55

Today's Snapshot

AI-generated

DSGN closed 1.4% below yesterday's close, while its sector was flat. Design Therapeutics reported improved biomarkers and clinical measures for DT-216, its experimental drug for Friedreich’s ataxia.

Trading Volume

Above 10d avg 633.4K

812.2K

vs S&P 500 Today

Underperforming Market

-0.96%

Updated: September 9, 2026 at 20:13 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
DSGN presents a cautiously positive technical profile, with the stock trading just under short-term averages but above its 50- and longer-term moving averages, which signals medium-term support. Momentum is muted—RSI near the mid-50s and MACD slightly positive—while faster oscillators are neutral, pointing to a lack of strong directional conviction. ADX is below 20, indicating a weak trend, and volatility is moderate per ATR. On-balance volume shows some distribution, which warrants caution despite the moving-average support. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$11.55 - $15.16
    Buy
  • RSI (14)53.96
    Neutral
  • Stochastic %K (14, 3, 3)44.35
    Neutral
  • MACD Level (12, 26)0.37
    Neutral

Peers & Related Assets

AURAAura Biosciences, Inc.
$7.2-2.2%
ANNXAnnexon, Inc.
$4.37-6.4%
ALTAltimmune, Inc.
$3.35-0.3%
RCKTRocket Pharmaceuticals, Inc.
$3.63-2.2%
KRROKorro Bio, Inc.
$12.93-4.3%
LBRXLB Pharmaceuticals Inc Common Stock
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.